Samsung is poised to make significant strides in the health technology sector with its upcoming Galaxy Ring, potentially surpassing Apple in integrating groundbreaking features like continuous blood pressure monitoring and noninvasive blood glucose readings into wearable devices.
The Galaxy Ring, expected to launch in 2024, represents Samsung’s commitment to advancing health tracking technology. In a Bloomberg interview, Samsung health executive Hon Pak revealed the company’s ambitious goals to incorporate continuous blood pressure and glucose monitoring into its devices. These features, currently beyond the capabilities of consumer-level smartwatches and fitness trackers, could revolutionize how individuals manage their health.
According to Pak, achieving noninvasive glucose monitoring is a significant focus for Samsung, with the technology expected to materialize in some form within the next five years. The challenge lies in developing a method that allows continuous, accurate monitoring without the need for invasive procedures like the traditional finger-prick test used by diabetics. Current non-invasive glucose monitors, which adhere to the skin, require frequent replacement, making them unsuitable for integration into a smartwatch.
The Galaxy Ring, apart from its activity and sleep tracking capabilities, is anticipated to bring more advanced health features in the future. Pak emphasized the device’s design, catering to users seeking health tracking in a more comfortable and less obtrusive form. This innovation aligns with a growing demand for wearable health technologies that are both effective and unobtrusive.
Beyond the Galaxy Ring, Samsung is exploring the integration of health sensors into future versions of the Samsung Galaxy Buds. These enhancements could include features focusing on meditation and mental health, potentially in conjunction with virtual reality headsets. This expansion indicates Samsung’s holistic approach to health and wellness technology.
While Samsung forges ahead, Apple is not far behind in the race to integrate blood glucose monitoring technology into its Apple Watches. However, Apple’s progress may be hampered by ongoing patent disputes, potentially delaying the release of these advanced health features.
